Your science and technology news reporter

Provided by AGP

Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

Press releases published on May 6, 2026

Unravel Biosciences Announces Publication of the First Validated Spanish Language Rett Syndrome Behavioral Questionnaire
Haiqu Launches Agentic Quantum Operating System for Enterprise Applications R&D
Financial Results for the First Quarter of 2026
South Star Announces Non-Brokered Private Placement
Maker Faire Rome 2026 Opens Global Call for Makers, Schools and Researchers
Crypto News Today: AlphaPepe Presale Crosses $1.1M Whilst Bitcoin Price Prediction Points To $250,000
Non-destructive homogeneity measurement for transparent cylindrical materials without slicing
Aura Announces Q1 2026 Financial and Operational Results, Another High Record Adjusted EBITDA
Fiber endoscopy: Physics-guided network erases honeycomb artifacts
Ballad Health Academy welcomes second class of students amid new program offerings and expansions
Axavive Skin Exploding in 2026: Can This “Golden Seed Switch” Really Transform Your Skin?
Image Analysis Group × HeartcoR Solutions – Press Release
RevitalVision, a Digital Therapeutic, Demonstrates Efficacy and Safety in Infantile Nystagmus
Behavidence Launches Clinical Partnership Program to Advance Mental Health RTM with Passive Digital Biomarkers
Orezone Provides Notice of First Quarter 2026 Results
Aura Declares Dividend of US$0.78 Per Share and US$0.26 Per BDR Based on Q1 2026 Results, Resulting in a Dividend Yield of 4.5% in the LTM
Imperial Reports First Quarter 2026 Financial Results
Taseko Announces Continued Strong Operational and Financial Results in the First Quarter 2026
Inspired Entertainment Extends Long-Term Agreement with Paddy Power for Gaming Terminals and Content
Totus Medicines Presents Early Phase 1b Clinical Data Demonstrating 100% Disease Control Rate and Class-Leading Safety for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER2- Breast Cancer at ESMO Breast Cancer Annual Congress 2026

Share us

on your social networks:

Sign up for:

Science & Technology Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.